NCT00455494View on ClinicalTrials.gov

Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Malaria
Interventions
DRUG

AQ-13

Trial Locations (1)

70112

Tulane-LSU General Clinical Research Center, New Orleans

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Tulane University Health Sciences Center

OTHER

NCT00455494 - Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial | Biotech Hunter | Biotech Hunter